IDiyas

For the Inventor, By the Inventor

San Jose, CA, United States of America

Kun Wang

USPTO Granted Patents = 13 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal13 out of 1,826 
 
Tencent America LLC
 patents

Years Active: 2021-2024

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):
1. 11986307 - Digital signal processing assistant modeling method for biosignal analysis (2024-05-21),
2. 11763944 - System and method for clinical decision support system with inquiry based on reinforcement learning (2023-09-19),
3. 11610326 - Synthesizing 3D hand pose based on multi-modal guided generative networks (2023-03-21),
4. 11610315 - System and method for identifying target regions prior to organs at risk segmentation (2023-03-21),
5. 11596344 - Deep neural network on ECG Poincare plot for atrial fibrillation classification (2023-03-07),
6. 11521743 - Framework for performing electrocardiography analysis (2022-12-06),
7. 11450424 - Training framework for multi-group electrocardiography (MG-ECG) analysis (2022-09-20),
8. 11432727 - SpO2 miniprogram: AI SpO2 measurement app (2022-09-06),
9. 11410302 - Two and a half dimensional convolutional neural network for predicting hematoma expansion in non-contrast head computerized tomography images (2022-08-09),
10. 11324457 - Explainable artificial intelligence framework for electrocardiography analysis (2022-05-10),
11. 11176699 - Augmenting reliable training data with CycleGAN for hand pose estimation (2021-11-16),
12. 11113817 - System and method for identifying target regions prior to organs at risk segmentation (2021-09-07),
13. 11103142 - System and method for predicting vertebral artery dissection (2021-08-31),

Title: Innovations by Kun Wang: A Pioneer in Biosignal Analysis

Introduction

Kun Wang is an accomplished inventor based in San Jose, California. He has made significant contributions to the field of biosignal analysis, holding a total of 13 patents. His work focuses on developing advanced methods and systems that enhance medical decision-making and analysis.

Latest Patents

Among his latest patents is a "Digital signal processing assistant modeling method for biosignal analysis." This innovative method and apparatus involve receiving an input biosignal and identifying the associated biosignal analysis task. The process includes selecting a waveform model and a digital signal processing (DSP) model, identifying features of the input biosignal, and performing the analysis task using the selected model.

Another notable patent is the "System and method for clinical decision support system with inquiry based on reinforcement learning." This method includes receiving medical information related to a user and determining inquiry information based on that data and a reinforcement learning model. The system allows for the reception of response information, which is then used to determine diagnosis information through a machine learning model.

Career Highlights

Kun Wang is currently employed at Tencent America LLC, where he continues to innovate in the field of biosignal analysis. His work has been instrumental in advancing technologies that support clinical decision-making and improve patient outcomes.

Collaborations

Some of his notable coworkers include Wei Fan and Min Tu, who collaborate with him on various projects and innovations.

Conclusion

Kun Wang's contributions to biosignal analysis and clinical decision support systems highlight his role as a leading inventor in the field. His innovative patents reflect a commitment to improving healthcare through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…